Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme

Journal of Epidemiology and Community Health

Volumn 52, Issue 2, 1998, Pages 111-115

  Moss, Sue ^a   Blanks, Roger ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CALCULATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; NATIONAL HEALTH SERVICE; NORMAL HUMAN;

EID: 0031974676     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.52.2.111     Document Type: Article

References (20)

1. Forrest APM. Breast cancer screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: H M Stationery Office, 1986.
2. Quality Assurance Guidelines for Mammography (Pritchard Report). Oxford: NHSBSP, 1989.
3. Objectives for the NHSBSP. Oxford: January 1993.
4. Tabar L, Gad A, Holmberg LH, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985;i:829-32.
5. Patnick J, Muir Gray JA. Guidelines on the collection and use of breast cancer data. Sheffield: NHSBSP Publication no 26, 1993.
6. Tabar L, Fagerberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? Br J Cancer 1987;55:547-51.
7. Blanks RG, Day NE, Moss SM. Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate. J Med Screen 1996;3:79-81.
8. Prior P, Woodman CBJ, Wilson S, Threlfall AG. Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screen 1996;3:119-22.
9. UK Trial of Early Detection of Breast Cancer Group. Trial of early detection of breast cancer: description of method. Br J Cancer 1981;44:618-27.
10. Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 1995;311:1189-93.
11. Moss SM, Michel M, Patnick J, Johns L, Blanks R, Chamberlain J. Results from the NHS breast screening programme 1990-1993. J Med Screen 1995;2:186-90.
12. Mortality statistics: cause. England and Wales 1987. London: OPCS Series DH2, no 14. HMSO, 1989.
13. Duffy SW, Tabar L, Fagerberg G, et al. Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer 1991;64:1133-8.
14. Day NE, Williams DRR, Kaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-8.
15. Woodman CBJ, Threlfall A, Boggis CRM, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 1995;310:224-6.
16. Day N, McCann J, Camilleri-Ferrante C, et al. Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screen 1995;2:180-5.
17. UK Trial of Early Detection of Breast Cancer Group. First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer. Lancet 1988;ii:411-16.
18. Blanks RG, Moss SM. Monitoring the performance of the breast screening programmes: allowing for geographical variation in breast cancer incidence. J Med Screen 1996;3:82-1.
19. Ikeda DM, Andersson I, Wattsgard C, Janzon L, Linell F. Interval cancinomas in the Malmo mammographic screening trial: radiographic appearance and prognostic considerations. Am J Radiol 1992;159:287-94.
20. Frisell J, Eklund G, Hellstrom L, Somell A. Analysis of interval carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 1987;3:219-25.